Selective Regulation of Bone Cell Apoptosis by Translational Isoforms of the Glucocorticoid Receptor
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are widely used in the treatment of inflammatory and other diseases. However, high-dose or chronic administration often triggers troublesome side effects such as metabolic syndrome and osteoporosis. We recently described that one glucocorticoid receptor gene produces eight translational glucocorticoid receptor isoforms that have distinct gene-regulatory abilities. We show here that specific, but not all, glucocorticoid receptor isoforms induced apoptosis in human osteosarcoma U-2 OS bone cells. Whole human genome microarray analysis revealed that the majority of the glucocorticoid target genes were selectively regulated by specific glucocorticoid receptor isoforms. Real-time PCR experiments confirmed that proapoptotic enzymes necessary for cell death, granzyme A and caspase-6, were induced by specific glucocorticoid receptor isoforms. Chromatin immunoprecipitation assays further suggested that glucocorticoid receptor isoform-dependent induction of proapoptotic genes was likely due to selective coregulator recruitment and chromatin modification. Interestingly, the capabilities to transrepress proinflammatory genes were similar among glucocorticoid receptor isoforms. Together, these findings provide new evidence that translational glucocorticoid receptor isoforms can elicit distinct glucocorticoid responses and may be useful for the development of safe glucocorticoids with reduced side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When individual isoforms are expressed in U2OS osteosarcoma or Jurkat T lymphoblastic leukemia cells, they each regulate a unique set of genes, with less than 10% being commonly regulated by all the isoforms64, 65.”
From Corticosteroids (2016) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An interesting difference among the GRα isoforms, is that each GR variant possesses a distinct transcription profile.”
From Corticosteroids (2016) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · cited 1×
“gov/geo/) (7) and are accessible through Gene Expression Omnibus series ac-”
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 1×
“Glucocorticoids are widely used in the clinic to treat a variety of diseases including inflammation, cancer, and autoimmune disorders (23).”
BackgroundSelf-citationMineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628 · cited 1×
“Although tissue-selective ligand availability and cofactor recruitment can partially explain the cell typeselective effects of glucocorticoids (1, 9, 11, 12), recent evidence suggests that tissue-selective expression of glucocorticoid receptor (GR) isoforms may also play a critical role in the tissue-selective respons…”
BackgroundScheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819 · cited 3×
“FIG. 7. GR isoforms differentially recruit cofactors onto the GZMA promoter region ( 27 ).”
BackgroundMethodSelf-citationO’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2004) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771 · cited 1×
“Studies of transgenic animals overexpressing 11- -hydroxysteroid dehydrogenase 2, an enzyme that reduces the active corticosteroid level, in osteoblasts and osteocytes suggest that glucocorticoids exert their cell-killing effects directly on bone cells (21).”
BackgroundCloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712 · cited 1×
“Although tissue-selective ligand availability and cofactor recruitment can partially explain the cell typeselective effects of glucocorticoids (1, 9, 11, 12), recent evidence suggests that tissue-selective expression of glucocorticoid receptor (GR) isoforms may also play a critical role in the tissue-selective respons…”
BackgroundLu, N. Z., & Cidlowski, J. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.025 · Cited by 455 · cited 10×
“(18) were transfected into COS-1 cells using Transit LT1 reagent at 3 l per 1 g”
BackgroundMethodSelf-citationWallace, A. D., & Cidlowski, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106033200 · Cited by 394 · cited 1×
“2B), indicating that all GR isoforms are fully capable of undergoing ligand-dependent downregulation (31).”
BackgroundSelf-citationRosetta error model for gene expression analysis
Weng, L., Dai, H., Zhan, Y., He, Y., Stepaniants, S. B., & Bassett, D. E. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl045 · Cited by 305 · cited 1×
“This system performs data preprocessing and error modeling ( 33 ).”
MethodA Tissue-Specific Coactivator of Steroid Receptors, Identified in a Functional Genetic Screen
Knutti, D., Kaul, A., & Kralli, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2411-2422.2000 · Cited by 288 · cited 1×
“Although tissue-selective ligand availability and cofactor recruitment can partially explain the cell typeselective effects of glucocorticoids (1, 9, 11, 12), recent evidence suggests that tissue-selective expression of glucocorticoid receptor (GR) isoforms may also play a critical role in the tissue-selective respons…”
BackgroundRogatsky, I., Trowbridge, J. M., & Garabedian, M. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3181 · Cited by 257 · cited 1×
“The GR-mediated apoptosis reported here may complement the GR-mediated cell cycle arrest reported previously for osteoporosis (25).”
BackgroundGlucocorticoid receptor isoforms generate transcription specificity
Lu, N. Z., & Cidlowski, J. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.005 · Cited by 248 · cited 1×
“GR isoforms include GR and GR , which are generated via alternative splicing, with GR being expressed at relatively higher levels in the majority of the tissues examined (17).”
BackgroundSelf-citationTarget-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor
Rogatsky, I., Wang, J.-C., Derynck, M. K., Nonaka, D. F., Khodabakhsh, D. B., Haqq, C. M., Darimont, B. D., Garabedian, M. J., & Yamamoto, K. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336092100 · Cited by 241 · cited 1×
“Whole human genome surveys and unique contributions from individual GR isoforms result in such a large number compared to those obtained by microarray analyses performed previously by other groups (15, 26).”
ResultMOLECULAR MECHANISMS OF GLUCOCORTICOIDS IN THE CONTROL OF INFLAMMATION AND LYMPHOCYTE APOPTOSIS
Tuckermann, J. P., Kleiman, A., McPherson, K. G., & Reichardt, H. M. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360590888983 · Cited by 202 · cited 2×
“In agreement with data in the literature, there is a delayed onset of cell death in our model system, suggesting that the proapoptotic action of glucocorticoids requires GR-mediated transcription (22, 29, 35).”
BackgroundMolecular mechanisms of glucocorticoid-induced osteoporosis.
Patschan, D., Loddenkemper, K., & Buttgereit, F. (2001) · Bone · doi:10.1016/s8756-3282(01)00610-x · Cited by 201 · cited 3×
“Osteoporosis, for instance, is one of the side effects that can be life-threatening (22).”
BackgroundGlucocorticoid-Induced Osteoporosis
Weinstein, R. S. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010007108155 · Cited by 189
Expanding functional diversity of the coactivators
Lonard, D. M., & O'Malley, B. W. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.001 · Cited by 172 · cited 1×
“The Nterminal domain contains the main transactivation activity of the receptor and the residues pivotal in ligand-dependent coregulator recruitment (16).”
BackgroundTissue glucocorticoid resistance/hypersensitivity syndromes
Kino, T., Martino, M. U. D., Charmandari, E., Mirani, M., & Chrousos, G. P. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00218-8 · Cited by 169 · cited 1×
“For example, tissue-specific glucocorticoid resistance after chronic exposure frequently occurs in patients with rheumatoid arthritis, osteoarthritis, Crohn’s disease, ulcerative colitis, and asthma (10).”
BackgroundRegulation of apoptosis in osteoclasts and osteoblastic cells
Xing, L., & Boyce, B. F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.072 · Cited by 163 · cited 1×
“Other authors reported previously that cell survival factors such as insulin-like growth factor, IL-6, integrins, and matrix metalloproteinases can be suppressed by glucocorticoids (34), and conversely, proapoptotic factors such as caspases may be increased by glucocorticoids (5, 13).”
BackgroundChrysis, D., Zaman, F., Chagin, A. S., Takigawa, M., & Sävendahl, L. (2005) · Endocrinology · doi:10.1210/en.2004-1152 · Cited by 142 · cited 1×
“Several genes, including GZMA and CASP6, have been suggested to participate in glucocorticoid-induced killing of osteoblasts, chondrocytes, and lymphocytes (4, 28, 30, 35).”
BackgroundCidlowski, J. A., Bellingham, D. L., Powell-Oliver, F. E., Lubahn, D. B., & Sar, M. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-10-1427 · Cited by 139 · cited 1×
“Rabbit anti-GR antibody 57 was previously described (6).”
BackgroundSelf-citationMechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates
Frankfurt, O., & Rosen, S. T. (2004) · Current Opinion in Oncology · doi:10.1097/01.cco.0000142072.22226.09 · Cited by 136 · cited 1×
“regulation; a decision stage, which triggers apoptotic factors at the mitochondrial level; and an execution stage, which activates proapoptotic caspases and endonucleases (8).”
BackgroundFas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis
Kogianni, G., Mann, V., Ebetino, F. H., NUTTALL, M. E., Nijweide, P. J., Simpson, H., & Noble, B. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.048 · Cited by 117 · cited 1×
“Other authors reported previously that cell survival factors such as insulin-like growth factor, IL-6, integrins, and matrix metalloproteinases can be suppressed by glucocorticoids (34), and conversely, proapoptotic factors such as caspases may be increased by glucocorticoids (5, 13).”
BackgroundGene expression profiling of glucocorticoid-inhibited osteoblasts
Leclerc, N., Luppen, C., Ho, V., Nagpal, S., Hacia, J., Smith, E., & Frenkel, B. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0330175 · Cited by 115
Rogatsky, I., Hittelman, A. B., Pearce, D., & Garabedian, M. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5036 · Cited by 107 · cited 1×
“reported previously that the downregulation of the antiapoptotic Bcl-2 gene may contribute to the cell-killing effects of glucocorticoids in U-2 OS cells (24).”
BackgroundIdentification of novel direct transcriptional targets of glucocorticoid receptor
U, M., Shen, L., Oshida, T., Miyauchi, J., Yamada, M., & Miyashita, T. (2004) · Leukemia · doi:10.1038/sj.leu.2403516 · Cited by 97
TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain
Kumar, R., Volk, D. E., Li, J., Lee, J. C., Gorenstein, D. G., & Thompson, E. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407160101 · Cited by 86 · cited 1×
“While this notion is still speculative, recent evidence supports the hypothesis that after ligand and DNA binding, the GR N-terminal domain folds into an organized structure that promotes both intra- and intermolecular interactions and cofactor recruitment (14).”
BackgroundKo, L., Cardona, G. R., Henrion-Caude, A., & Chin, W. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.357-369.2002 · Cited by 84
Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells
Chua, C. C., Chua, B. H. L., Chen, Z., Landy, C., & Hamdy, R. C. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(03)00100-9 · Cited by 63 · cited 1×
“Other authors reported previously that cell survival factors such as insulin-like growth factor, IL-6, integrins, and matrix metalloproteinases can be suppressed by glucocorticoids (34), and conversely, proapoptotic factors such as caspases may be increased by glucocorticoids (5, 13).”
BackgroundTsujimoto, K., Ono, T., Sato, M., Nishida, T., Oguma, T., & Tadakuma, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501304200 · Cited by 49 · cited 1×
“Several genes, including GZMA and CASP6, have been suggested to participate in glucocorticoid-induced killing of osteoblasts, chondrocytes, and lymphocytes (4, 28, 30, 35).”
BackgroundSteroid Receptor Number: Individual Variation and Downregulation by Treatment
Brönnegård, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s28 · Cited by 33 · cited 1×
“Responsiveness to glucocorticoid therapy, however, differs considerably among patients, and even within the same individual, different tissues have different glucocorticoid responsivenesses (3).”
BackgroundNecela, B. M., & Cidlowski, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405489200 · Cited by 22 · cited 1×
“by on March 29, 2010 mcb.asm.org Downloaded from sured as previously described ( 19 ).”
MethodSelf-citationGranzyme A mediates glucocorticoid-induced apoptosis in leukemia cells
YAMADA, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1116fje · Cited by 21
Necela, B. M. (2003) · Steroids · doi:10.1016/s0039-128x(03)00032-1 · Cited by 15 · cited 1×
“for Western blot analysis were previously described (20).”
Background
Cited by
Immune regulation by glucocorticoids
Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846
Self-citationThe biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
“The GRα translational isoforms display a similar affinity for glucocorticoids and a similar capacity to interact with GREs following ligand activation; however, they show marked differences in other properties (8, 15).”
BackgroundSelf-citationRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Self-citationA General Introduction to Glucocorticoid Biology
Timmermans, S., Souffriau, J., & Libert, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01545 · Cited by 609
“In vitro work proved that these isoforms do have the capability to regulate distinct transcriptional programs (96).”
BackgroundSurjit, M., Ganti, K. P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., & Chambon, P. (2011) · Cell · doi:10.1016/j.cell.2011.03.027 · Cited by 551
Metadata
- Authors
- Lu, N. Z., Collins, J. B., Grissom, S. F., & Cidlowski, J. A.
- Affiliations
- Molecular Endocrinology Group, Laboratory of Signal Transduction
- National Institutes of Health (US)
- Corresponding author
- Cidlowski, John A.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-10-01
- Volume
- 27
- Issue
- 20
- Pages
- 7143-7160
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2168898
- OpenAlex
- W2164942621
- Cited by
- 160
- References
- 35
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 12 · 2018: 8 · 2017: 16 · 2016: 11 · 2015: 9 · 2014: 12 · 2013: 12 · 2012: 9
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Northwestern University
- National Institutes of Health
- National Institute of Environmental Health Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- glucocorticoid receptor, alternative splicing, granzyme A, caspase-6, coregulator recruitment, chromatin modification, glucocorticoid adverse effects, osteoporosis, metabolic syndrome
- MeSH terms
- Animals, Bone and Bones, Chlorocebus aethiops, Dexamethasone, Glucocorticoids, Humans, Male, Mice, Inbred C57BL, Molecular Sequence Data, Receptors, Glucocorticoid, Osteosarcoma, Protein Biosynthesis, Cluster Analysis, Apoptosis, COS Cells, Protein Isoforms, Caspases, Gene Expression Profiling, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.